Hattinger, C.M.; Patrizio, M.P.; Fantoni, L.; Casotti, C.; Riganti, C.; Serra, M.
Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies. Cancers 2021, 13, 2878.
https://doi.org/10.3390/cancers13122878
AMA Style
Hattinger CM, Patrizio MP, Fantoni L, Casotti C, Riganti C, Serra M.
Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies. Cancers. 2021; 13(12):2878.
https://doi.org/10.3390/cancers13122878
Chicago/Turabian Style
Hattinger, Claudia Maria, Maria Pia Patrizio, Leonardo Fantoni, Chiara Casotti, Chiara Riganti, and Massimo Serra.
2021. "Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies" Cancers 13, no. 12: 2878.
https://doi.org/10.3390/cancers13122878
APA Style
Hattinger, C. M., Patrizio, M. P., Fantoni, L., Casotti, C., Riganti, C., & Serra, M.
(2021). Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies. Cancers, 13(12), 2878.
https://doi.org/10.3390/cancers13122878